Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UBM was a leading global business-to-business event organizer and marketing services company with a significant footprint in the healthcare and life sciences sectors. Through its UBM Life Sciences and UBM Medica divisions, the company managed a portfolio of influential trade publications and professional journals, including Pharmaceutical Technology, BioPharm International, and Medical Economics. UBM was also the organizer of CPhI, the world's largest series of pharmaceutical ingredients exhibitions, which serves as a critical networking hub for the global drug manufacturing industry. In 2018, UBM was acquired by Informa plc for approximately £3.9 billion, creating one of the world's largest information services and events groups. Its legacy healthcare assets continue to operate under Informa's various divisions, providing data and connectivity to the pharmaceutical and medical communities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on United Business Media.